Per Hellsund is the founder of Cybrexa Therapeutics. Cybrexa Therapeutics has raised $6M in total funding. Latest round: Series B.
Per Hellsund is the CEO of Cybrexa Therapeutics, an oncology biotechnology company based in New Haven, developing peptide drug conjugate therapies. He is described as a bioscience entrepreneur and has been with Cybrexa Therapeutics since January 2017.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide